Compile Data Set for Download or QSAR

Found 105 hits of ec50 for UniProtKB: P05231   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Interleukin-6 (Homo sapiens (Human))	BDBM423528 (US10508115, Compound If-04) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Nc4ccc(CNC5CCC5)cc4)nc3)c2n1 Show InChI InChI=1S/C26H32N8O2/c1-2-3-13-36-25-32-23(27)22-24(33-25)34(26(35)31-22)16-18-9-12-21(29-15-18)30-20-10-7-17(8-11-20)14-28-19-5-4-6-19/h7-12,15,19,28H,2-6,13-14,16H2,1H3,(H,29,30)(H,31,35)(H2,27,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	2.5	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423493 (US10508115, Compound Ib-12) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCC(C)C)cc4)nc3)c2n1 Show InChI InChI=1S/C26H33N7O3/c1-4-5-12-35-25-31-23(27)22-24(32-25)33(26(34)30-22)16-19-8-11-21(29-15-19)36-20-9-6-18(7-10-20)14-28-13-17(2)3/h6-11,15,17,28H,4-5,12-14,16H2,1-3H3,(H,30,34)(H2,27,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	3.77	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423530 (US10508115, Compound If-06) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Nc4ccc(CN5CCCC5)cc4)nc3)c2n1 Show InChI InChI=1S/C26H32N8O2/c1-2-3-14-36-25-31-23(27)22-24(32-25)34(26(35)30-22)17-19-8-11-21(28-15-19)29-20-9-6-18(7-10-20)16-33-12-4-5-13-33/h6-11,15H,2-5,12-14,16-17H2,1H3,(H,28,29)(H,30,35)(H2,27,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	3.80	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM419194 (US10457681, Compound Ia-02 | US10487084, Compound ...) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc4N(C)c5ccc(CNC(C)C)cc5Sc4c3)c2n1 Show InChI InChI=1S/C27H33N7O2S/c1-5-6-11-36-26-31-24(28)23-25(32-26)34(27(35)30-23)15-18-8-10-20-22(13-18)37-21-12-17(14-29-16(2)3)7-9-19(21)33(20)4/h7-10,12-13,16,29H,5-6,11,14-15H2,1-4H3,(H,30,35)(H2,28,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	4.90	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Companay US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10981914 (2021) BindingDB Entry DOI: 10.7270/Q23X89RG
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM419194 (US10457681, Compound Ia-02 | US10487084, Compound ...) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc4N(C)c5ccc(CNC(C)C)cc5Sc4c3)c2n1 Show InChI InChI=1S/C27H33N7O2S/c1-5-6-11-36-26-31-24(28)23-25(32-26)34(27(35)30-23)15-18-8-10-20-22(13-18)37-21-12-17(14-29-16(2)3)7-9-19(21)33(20)4/h7-10,12-13,16,29H,5-6,11,14-15H2,1-4H3,(H,30,35)(H2,28,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	4.90	n/a	n/a	n/a	n/a
Bristol_Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10457681 (2019) BindingDB Entry DOI: 10.7270/Q2N87D54
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423496 (US10508115, Compound Ib-15 | US10508115, Compound ...) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCC5CC5)cc4)nc3)c2n1 Show InChI InChI=1S/C26H31N7O3/c1-2-3-12-35-25-31-23(27)22-24(32-25)33(26(34)30-22)16-19-8-11-21(29-15-19)36-20-9-6-18(7-10-20)14-28-13-17-4-5-17/h6-11,15,17,28H,2-5,12-14,16H2,1H3,(H,30,34)(H2,27,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	5.11	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423488 (US10508115, Compound Ib-07) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCCOC)cc4)nc3)c2n1 Show InChI InChI=1S/C25H31N7O4/c1-3-4-12-35-24-30-22(26)21-23(31-24)32(25(33)29-21)16-18-7-10-20(28-15-18)36-19-8-5-17(6-9-19)14-27-11-13-34-2/h5-10,15,27H,3-4,11-14,16H2,1-2H3,(H,29,33)(H2,26,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	5.81	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423490 (US10508115, Compound Ib-09) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5C6CC5C6)cc4)nc3)c2n1 |THB:25:26:28:30,(-13.4,4.64,;-12.07,5.41,;-10.73,4.64,;-9.4,5.41,;-8.07,4.64,;-6.73,5.41,;-6.73,6.95,;-5.4,7.72,;-5.4,9.26,;-4.07,6.95,;-2.6,7.43,;-1.7,6.18,;-.16,6.18,;-2.6,4.94,;-2.6,3.4,;-1.27,2.63,;.07,3.4,;1.4,2.63,;1.4,1.09,;2.73,.32,;4.07,1.09,;5.4,.32,;6.73,1.09,;6.73,2.63,;8.07,3.4,;8.07,4.94,;6.73,5.71,;5.19,5.71,;5.49,8.15,;5.49,6.61,;4.15,5.84,;5.4,3.4,;4.07,2.63,;.07,.32,;-1.27,1.09,;-4.07,5.41,;-5.4,4.64,)| Show InChI InChI=1S/C27H31N7O3/c1-2-3-10-36-26-32-24(28)23-25(33-26)34(27(35)31-23)15-17-6-9-21(29-14-17)37-20-7-4-16(5-8-20)13-30-22-18-11-19(22)12-18/h4-9,14,18-19,22,30H,2-3,10-13,15H2,1H3,(H,31,35)(H2,28,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	5.91	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423480 (US10508115, Compound Ia-07) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCCOC)cc4)cc3)c2n1 Show InChI InChI=1S/C26H32N6O4/c1-3-4-14-35-25-30-23(27)22-24(31-25)32(26(33)29-22)17-19-7-11-21(12-8-19)36-20-9-5-18(6-10-20)16-28-13-15-34-2/h5-12,28H,3-4,13-17H2,1-2H3,(H,29,33)(H2,27,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	6.62	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM419219 (US10457681, Compound Ia-04 | US10487084, Compound ...) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc4N(C)c5ccc(CNC)cc5Sc4c3)c2n1 Show InChI InChI=1S/C25H29N7O2S/c1-4-5-10-34-24-29-22(26)21-23(30-24)32(25(33)28-21)14-16-7-9-18-20(12-16)35-19-11-15(13-27-2)6-8-17(19)31(18)3/h6-9,11-12,27H,4-5,10,13-14H2,1-3H3,(H,28,33)(H2,26,29,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	6.90	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...				US Patent US10487084 (2019) BindingDB Entry DOI: 10.7270/Q2P55QX7
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423484 (US10508115, Compound Ib-03) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC(C)C)cc4)nc3)c2n1 Show InChI InChI=1S/C25H31N7O3/c1-4-5-12-34-24-30-22(26)21-23(31-24)32(25(33)29-21)15-18-8-11-20(28-14-18)35-19-9-6-17(7-10-19)13-27-16(2)3/h6-11,14,16,27H,4-5,12-13,15H2,1-3H3,(H,29,33)(H2,26,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	7.5	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM420041 (US10487084, Compound Ib-02) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(nc3)-c3csc(CN)c3)c2n1 Show InChI InChI=1S/C20H23N7O2S/c1-2-3-6-29-19-25-17(22)16-18(26-19)27(20(28)24-16)10-12-4-5-15(23-9-12)13-7-14(8-21)30-11-13/h4-5,7,9,11H,2-3,6,8,10,21H2,1H3,(H,24,28)(H2,22,25,26)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	UniChem	US Patent	n/a	n/a	n/a	n/a	7.55	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...				US Patent US10487084 (2019) BindingDB Entry DOI: 10.7270/Q2P55QX7
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423522 (US10508115, Compound Ie-08) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5CCOCC5)cc4)c(F)c3)c2n1 Show InChI InChI=1S/C28H33FN6O4/c1-2-3-12-38-27-33-25(30)24-26(34-27)35(28(36)32-24)17-19-6-9-23(22(29)15-19)39-21-7-4-18(5-8-21)16-31-20-10-13-37-14-11-20/h4-9,15,20,31H,2-3,10-14,16-17H2,1H3,(H,32,36)(H2,30,33,34)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	7.60	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423531 (US10508115, Compound If-07) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Nc4ccc(CNCC(C)(C)O)cc4)nc3)c2n1 Show InChI InChI=1S/C26H34N8O3/c1-4-5-12-37-24-32-22(27)21-23(33-24)34(25(35)31-21)15-18-8-11-20(29-14-18)30-19-9-6-17(7-10-19)13-28-16-26(2,3)36/h6-11,14,28,36H,4-5,12-13,15-16H2,1-3H3,(H,29,30)(H,31,35)(H2,27,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	7.80	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423492 (US10508115, Compound Ib-11) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5CCCC5)cc4)nc3)c2n1 Show InChI InChI=1S/C27H33N7O3/c1-2-3-14-36-26-32-24(28)23-25(33-26)34(27(35)31-23)17-19-10-13-22(30-16-19)37-21-11-8-18(9-12-21)15-29-20-6-4-5-7-20/h8-13,16,20,29H,2-7,14-15,17H2,1H3,(H,31,35)(H2,28,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	8.14	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423486 (US10508115, Compound Ib-05) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5COC5)cc4)nc3)c2n1 Show InChI InChI=1S/C25H29N7O4/c1-2-3-10-35-24-30-22(26)21-23(31-24)32(25(33)29-21)13-17-6-9-20(28-12-17)36-19-7-4-16(5-8-19)11-27-18-14-34-15-18/h4-9,12,18,27H,2-3,10-11,13-15H2,1H3,(H,29,33)(H2,26,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	9.57	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423499 (US10508115, Compound Ic-01) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4cccc(CNCC(C)C)n4)cc3)c2n1 Show InChI InChI=1S/C26H33N7O3/c1-4-5-13-35-25-31-23(27)22-24(32-25)33(26(34)30-22)16-18-9-11-20(12-10-18)36-21-8-6-7-19(29-21)15-28-14-17(2)3/h6-12,17,28H,4-5,13-16H2,1-3H3,(H,30,34)(H2,27,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	10.1	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423477 (US10508115, Compound Ia-04) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5CCC5)cc4)cc3)c2n1 Show InChI InChI=1S/C27H32N6O3/c1-2-3-15-35-26-31-24(28)23-25(32-26)33(27(34)30-23)17-19-9-13-22(14-10-19)36-21-11-7-18(8-12-21)16-29-20-5-4-6-20/h7-14,20,29H,2-6,15-17H2,1H3,(H,30,34)(H2,28,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	10.4	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423487 (US10508115, Compound Ib-06) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCCO)cc4)nc3)c2n1 Show InChI InChI=1S/C24H29N7O4/c1-2-3-12-34-23-29-21(25)20-22(30-23)31(24(33)28-20)15-17-6-9-19(27-14-17)35-18-7-4-16(5-8-18)13-26-10-11-32/h4-9,14,26,32H,2-3,10-13,15H2,1H3,(H,28,33)(H2,25,29,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	10.7	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM483349 (US10919895, Compound Ic-13) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(CN4CCC(CN)CC4)nc3)c2n1 Show InChI InChI=1S/C22H32N8O2/c1-2-3-10-32-21-27-19(24)18-20(28-21)30(22(31)26-18)13-16-4-5-17(25-12-16)14-29-8-6-15(11-23)7-9-29/h4-5,12,15H,2-3,6-11,13-14,23H2,1H3,(H,26,31)(H2,24,27,28)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	11	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10919895 (2021) BindingDB Entry DOI: 10.7270/Q2KS6VNZ
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423511 (US10508115, Compound Id-05) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCCO)nc4)nc3)c2n1 Show InChI InChI=1S/C23H28N8O4/c1-2-3-10-34-22-29-20(24)19-21(30-22)31(23(33)28-19)14-15-4-7-18(27-11-15)35-17-6-5-16(26-13-17)12-25-8-9-32/h4-7,11,13,25,32H,2-3,8-10,12,14H2,1H3,(H,28,33)(H2,24,29,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	12	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM419194 (US10457681, Compound Ia-02 | US10487084, Compound ...) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc4N(C)c5ccc(CNC(C)C)cc5Sc4c3)c2n1 Show InChI InChI=1S/C27H33N7O2S/c1-5-6-11-36-26-31-24(28)23-25(32-26)34(27(35)30-23)15-18-8-10-20-22(13-18)37-21-12-17(14-29-16(2)3)7-9-19(21)33(20)4/h7-10,12-13,16,29H,5-6,11,14-15H2,1-4H3,(H,30,35)(H2,28,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	12.6	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...				US Patent US10487084 (2019) BindingDB Entry DOI: 10.7270/Q2P55QX7
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423510 (US10508115, Compound Id-04) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCCOC)nc4)nc3)c2n1 Show InChI InChI=1S/C24H30N8O4/c1-3-4-10-35-23-30-21(25)20-22(31-23)32(24(33)29-20)15-16-5-8-19(28-12-16)36-18-7-6-17(27-14-18)13-26-9-11-34-2/h5-8,12,14,26H,3-4,9-11,13,15H2,1-2H3,(H,29,33)(H2,25,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	13	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM483348 (US10919895, Compound Ic-12) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(CN4CCC(N)CC4)nc3)c2n1 Show InChI InChI=1S/C21H30N8O2/c1-2-3-10-31-20-26-18(23)17-19(27-20)29(21(30)25-17)12-14-4-5-16(24-11-14)13-28-8-6-15(22)7-9-28/h4-5,11,15H,2-3,6-10,12-13,22H2,1H3,(H,25,30)(H2,23,26,27)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	13	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10919895 (2021) BindingDB Entry DOI: 10.7270/Q2KS6VNZ
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423509 (US10508115, Compound Id-03) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5CCOCC5)nc4)nc3)c2n1 Show InChI InChI=1S/C26H32N8O4/c1-2-3-10-37-25-32-23(27)22-24(33-25)34(26(35)31-22)16-17-4-7-21(30-13-17)38-20-6-5-19(29-15-20)14-28-18-8-11-36-12-9-18/h4-7,13,15,18,28H,2-3,8-12,14,16H2,1H3,(H,31,35)(H2,27,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	14	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM483339 (US10919895, Compound Ic-03) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(CNC4CC4)nc3)c2n1 Show InChI InChI=1S/C19H25N7O2/c1-2-3-8-28-18-24-16(20)15-17(25-18)26(19(27)23-15)11-12-4-5-14(21-9-12)10-22-13-6-7-13/h4-5,9,13,22H,2-3,6-8,10-11H2,1H3,(H,23,27)(H2,20,24,25)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	14	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10919895 (2021) BindingDB Entry DOI: 10.7270/Q2KS6VNZ
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423527 (US10508115, Compound If-03) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Nc4ccc(CNC5CCOCC5)cc4)nc3)c2n1 Show InChI InChI=1S/C27H34N8O3/c1-2-3-12-38-26-33-24(28)23-25(34-26)35(27(36)32-23)17-19-6-9-22(30-16-19)31-21-7-4-18(5-8-21)15-29-20-10-13-37-14-11-20/h4-9,16,20,29H,2-3,10-15,17H2,1H3,(H,30,31)(H,32,36)(H2,28,33,34)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	14	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423491 (US10508115, Compound Ib-10) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5CC(F)(F)C5)cc4)nc3)c2n1 Show InChI InChI=1S/C26H29F2N7O3/c1-2-3-10-37-24-33-22(29)21-23(34-24)35(25(36)32-21)15-17-6-9-20(31-14-17)38-19-7-4-16(5-8-19)13-30-18-11-26(27,28)12-18/h4-9,14,18,30H,2-3,10-13,15H2,1H3,(H,32,36)(H2,29,33,34)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	14.3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM419208 (US10457681, Compound Ia-03 | US10487084, Compound ...) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc4N(C)c5ccc(CNCc6ccccc6)cc5Sc4c3)c2n1 Show InChI InChI=1S/C31H33N7O2S/c1-3-4-14-40-30-35-28(32)27-29(36-30)38(31(39)34-27)19-22-11-13-24-26(16-22)41-25-15-21(10-12-23(25)37(24)2)18-33-17-20-8-6-5-7-9-20/h5-13,15-16,33H,3-4,14,17-19H2,1-2H3,(H,34,39)(H2,32,35,36)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	14.4	n/a	n/a	n/a	n/a
Bristol_Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10457681 (2019) BindingDB Entry DOI: 10.7270/Q2N87D54
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM493082 (US10981914, Compound Ia-03) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc4N(C)c5ccc(CNc6ccccc6)cc5Sc4c3)c2n1 Show InChI InChI=1S/C30H31N7O2S/c1-3-4-14-39-29-34-27(31)26-28(35-29)37(30(38)33-26)18-20-11-13-23-25(16-20)40-24-15-19(10-12-22(24)36(23)2)17-32-21-8-6-5-7-9-21/h5-13,15-16,32H,3-4,14,17-18H2,1-2H3,(H,33,38)(H2,31,34,35)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	14.4	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Companay US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10981914 (2021) BindingDB Entry DOI: 10.7270/Q23X89RG
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423513 (US10508115, Compound Id-07) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CN5CCOCC5)nc4)nc3)c2n1 Show InChI InChI=1S/C25H30N8O4/c1-2-3-10-36-24-30-22(26)21-23(31-24)33(25(34)29-21)15-17-4-7-20(28-13-17)37-19-6-5-18(27-14-19)16-32-8-11-35-12-9-32/h4-7,13-14H,2-3,8-12,15-16H2,1H3,(H,29,34)(H2,26,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	15	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM419208 (US10457681, Compound Ia-03 | US10487084, Compound ...) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc4N(C)c5ccc(CNCc6ccccc6)cc5Sc4c3)c2n1 Show InChI InChI=1S/C31H33N7O2S/c1-3-4-14-40-30-35-28(32)27-29(36-30)38(31(39)34-27)19-22-11-13-24-26(16-22)41-25-15-21(10-12-23(25)37(24)2)18-33-17-20-8-6-5-7-9-20/h5-13,15-16,33H,3-4,14,17-19H2,1-2H3,(H,34,39)(H2,32,35,36)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	15	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Tech-nologies clear, V-bottom 384-well plate using ECHO acoustic liquid ha...				US Patent US10487084 (2019) BindingDB Entry DOI: 10.7270/Q2P55QX7
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423500 (US10508115, Compound Ic-02) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4cccc(CNC5CCC5)n4)cc3)c2n1 Show InChI InChI=1S/C26H31N7O3/c1-2-3-14-35-25-31-23(27)22-24(32-25)33(26(34)30-22)16-17-10-12-20(13-11-17)36-21-9-5-8-19(29-21)15-28-18-6-4-7-18/h5,8-13,18,28H,2-4,6-7,14-16H2,1H3,(H,30,34)(H2,27,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	16.1	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423529 (US10508115, Compound If-05) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Nc4ccc(CNCC(F)F)cc4)nc3)c2n1 Show InChI InChI=1S/C24H28F2N8O2/c1-2-3-10-36-23-32-21(27)20-22(33-23)34(24(35)31-20)14-16-6-9-19(29-12-16)30-17-7-4-15(5-8-17)11-28-13-18(25)26/h4-9,12,18,28H,2-3,10-11,13-14H2,1H3,(H,29,30)(H,31,35)(H2,27,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	17	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423479 (US10508115, Compound Ia-06) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCCO)cc4)cc3)c2n1 Show InChI InChI=1S/C25H30N6O4/c1-2-3-14-34-24-29-22(26)21-23(30-24)31(25(33)28-21)16-18-6-10-20(11-7-18)35-19-8-4-17(5-9-19)15-27-12-13-32/h4-11,27,32H,2-3,12-16H2,1H3,(H,28,33)(H2,26,29,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	17.3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423476 (US10508115, Compound Ia-03) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5CC5)cc4)cc3)c2n1 Show InChI InChI=1S/C26H30N6O3/c1-2-3-14-34-25-30-23(27)22-24(31-25)32(26(33)29-22)16-18-6-12-21(13-7-18)35-20-10-4-17(5-11-20)15-28-19-8-9-19/h4-7,10-13,19,28H,2-3,8-9,14-16H2,1H3,(H,29,33)(H2,27,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	17.6	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423495 (US10508115, Compound Ib-14) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCCS(C)(=O)=O)cc4)nc3)c2n1 Show InChI InChI=1S/C25H31N7O5S/c1-3-4-12-36-24-30-22(26)21-23(31-24)32(25(33)29-21)16-18-7-10-20(28-15-18)37-19-8-5-17(6-9-19)14-27-11-13-38(2,34)35/h5-10,15,27H,3-4,11-14,16H2,1-2H3,(H,29,33)(H2,26,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	18.9	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423516 (US10508115, Compound Ie-02) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5CCC5)cc4)c(F)c3)c2n1 Show InChI InChI=1S/C27H31FN6O3/c1-2-3-13-36-26-32-24(29)23-25(33-26)34(27(35)31-23)16-18-9-12-22(21(28)14-18)37-20-10-7-17(8-11-20)15-30-19-5-4-6-19/h7-12,14,19,30H,2-6,13,15-16H2,1H3,(H,31,35)(H2,29,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	19	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423517 (US10508115, Compound Ie-03) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CN5CCC5)cc4)c(F)c3)c2n1 Show InChI InChI=1S/C26H29FN6O3/c1-2-3-13-35-25-30-23(28)22-24(31-25)33(26(34)29-22)16-18-7-10-21(20(27)14-18)36-19-8-5-17(6-9-19)15-32-11-4-12-32/h5-10,14H,2-4,11-13,15-16H2,1H3,(H,29,34)(H2,28,30,31)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	19	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM483343 (US10919895, Compound Ic-07) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(CNCc4ccc(N)cc4)nc3)c2n1 Show InChI InChI=1S/C23H28N8O2/c1-2-3-10-33-22-29-20(25)19-21(30-22)31(23(32)28-19)14-16-6-9-18(27-12-16)13-26-11-15-4-7-17(24)8-5-15/h4-9,12,26H,2-3,10-11,13-14,24H2,1H3,(H,28,32)(H2,25,29,30)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	20	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10919895 (2021) BindingDB Entry DOI: 10.7270/Q2KS6VNZ
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423502 (US10508115, Compound Ic-04) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4cccc(CNC5CCOCC5)n4)cc3)c2n1 Show InChI InChI=1S/C27H33N7O4/c1-2-3-13-37-26-32-24(28)23-25(33-26)34(27(35)31-23)17-18-7-9-21(10-8-18)38-22-6-4-5-20(30-22)16-29-19-11-14-36-15-12-19/h4-10,19,29H,2-3,11-17H2,1H3,(H,31,35)(H2,28,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	20.7	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423514 (US10508115, Compound Id-08) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CN5CCN(C)CC5)nc4)nc3)c2n1 Show InChI InChI=1S/C26H33N9O3/c1-3-4-13-37-25-31-23(27)22-24(32-25)35(26(36)30-22)16-18-5-8-21(29-14-18)38-20-7-6-19(28-15-20)17-34-11-9-33(2)10-12-34/h5-8,14-15H,3-4,9-13,16-17H2,1-2H3,(H,30,36)(H2,27,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	21	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM483340 (US10919895, Compound Ic-04) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(CNC4CCC4)cc3)c2n1 Show InChI InChI=1S/C21H28N6O2/c1-2-3-11-29-20-25-18(22)17-19(26-20)27(21(28)24-17)13-15-9-7-14(8-10-15)12-23-16-5-4-6-16/h7-10,16,23H,2-6,11-13H2,1H3,(H,24,28)(H2,22,25,26)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	22	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10919895 (2021) BindingDB Entry DOI: 10.7270/Q2KS6VNZ
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM483347 (US10919895, Compound Ic-11) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(CNC4CCCC4)nc3)c2n1 Show InChI InChI=1S/C21H29N7O2/c1-2-3-10-30-20-26-18(22)17-19(27-20)28(21(29)25-17)13-14-8-9-16(23-11-14)12-24-15-6-4-5-7-15/h8-9,11,15,24H,2-7,10,12-13H2,1H3,(H,25,29)(H2,22,26,27)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	23	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10919895 (2021) BindingDB Entry DOI: 10.7270/Q2KS6VNZ
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423519 (US10508115, Compound Ie-05) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCCOC)cc4)c(F)c3)c2n1 Show InChI InChI=1S/C26H31FN6O4/c1-3-4-12-36-25-31-23(28)22-24(32-25)33(26(34)30-22)16-18-7-10-21(20(27)14-18)37-19-8-5-17(6-9-19)15-29-11-13-35-2/h5-10,14,29H,3-4,11-13,15-16H2,1-2H3,(H,30,34)(H2,28,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	24	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423525 (US10508115, Compound If-01) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Nc4ccc(CNCC(C)C)cc4)nc3)c2n1 Show InChI InChI=1S/C26H34N8O2/c1-4-5-12-36-25-32-23(27)22-24(33-25)34(26(35)31-22)16-19-8-11-21(29-15-19)30-20-9-6-18(7-10-20)14-28-13-17(2)3/h6-11,15,17,28H,4-5,12-14,16H2,1-3H3,(H,29,30)(H,31,35)(H2,27,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	24	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423481 (US10508115, Compound Ia-08) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCc5ccccc5)cc4)cc3)c2n1 Show InChI InChI=1S/C30H32N6O3/c1-2-3-17-38-29-34-27(31)26-28(35-29)36(30(37)33-26)20-23-11-15-25(16-12-23)39-24-13-9-22(10-14-24)19-32-18-21-7-5-4-6-8-21/h4-16,32H,2-3,17-20H2,1H3,(H,33,37)(H2,31,34,35)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	24.3	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423508 (US10508115, Compound Id-02) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNC5CCC5)nc4)nc3)c2n1 Show InChI InChI=1S/C25H30N8O3/c1-2-3-11-35-24-31-22(26)21-23(32-24)33(25(34)30-21)15-16-7-10-20(29-12-16)36-19-9-8-18(28-14-19)13-27-17-5-4-6-17/h7-10,12,14,17,27H,2-6,11,13,15H2,1H3,(H,30,34)(H2,26,31,32)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	25	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM423515 (US10508115, Compound Ie-01) Show SMILES CCCCOc1nc(N)c2nc(O)n(Cc3ccc(Oc4ccc(CNCC(C)C)cc4)c(F)c3)c2n1 Show InChI InChI=1S/C27H33FN6O3/c1-4-5-12-36-26-32-24(29)23-25(33-26)34(27(35)31-23)16-19-8-11-22(21(28)13-19)37-20-9-6-18(7-10-20)15-30-14-17(2)3/h6-11,13,17,30H,4-5,12,14-16H2,1-3H3,(H,31,35)(H2,29,32,33)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	26	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10508115 (2019) BindingDB Entry DOI: 10.7270/Q2K35X2W
					More data for this Ligand-Target Pair
Interleukin-6 (Homo sapiens (Human))	BDBM483337 (US10919895, Compound Ic-01) Show SMILES CCCCNCc1ccc(Cn2c(O)nc3c(N)nc(OCCCC)nc23)cn1 Show InChI InChI=1S/C20H29N7O2/c1-3-5-9-22-12-15-8-7-14(11-23-15)13-27-18-16(24-20(27)28)17(21)25-19(26-18)29-10-6-4-2/h7-8,11,22H,3-6,9-10,12-13H2,1-2H3,(H,24,28)(H2,21,25,26)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	26	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description Compounds diluted in DMSO were transferred to individual wells of a Matrix Technologies clear, V-bottom 384-well plate using ECHO acoustic liquid han...				US Patent US10919895 (2021) BindingDB Entry DOI: 10.7270/Q2KS6VNZ
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 105 total )  |  Next  |  Last  >>

Jump to: